3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
110
Head and Neck Neoplasms
97
Nasopharyngeal Carcinoma
36
Carcinoma, Non-Small-Cell Lung
21
Salivary Gland Neoplasms
17
Carcinoma, Squamous Cell
14
Laryngeal Neoplasms
12
Nasopharyngeal Neoplasms
10
Melanoma
10
Breast Neoplasms
10
Oropharyngeal Neoplasms
9
Hypopharyngeal Neoplasms
9
Stomach Neoplasms
8
Neoplasms
8
Esthesioneuroblastoma, Olfactory
8
Esophageal Neoplasms
8
Prostatic Neoplasms
7
Ovarian Neoplasms
7
Carcinoma, Renal Cell
7
Urinary Bladder Neoplasms
6
Tongue Neoplasms
6
Small Cell Lung Carcinoma
6
Recurrence
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Neoplasm Metastasis
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Mouth Neoplasms
4
Interventions
Cisplatin
7
Cetuximab
5
Drug Therapy
4
Radiotherapy
3
Resistance Training
2
Radiotherapy, Intensity-Modulated
2
Nutritional Status
2
Hydroxyurea
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Bevacizumab
2
zimberelimab
1
temsirolimus
1
pembrolizumab
1
Valproic Acid
1
Sirolimus
1
Radiation
1
Quality of Life
1
Psychology, Positive
1
Patient Reported Outcome Measures
1
Oncolytic Virotherapy
1
Molecular Diagnostic Techniques
1
Methods
1
Metabolic Flux Analysis
1
Immunotherapy
1
Immunoglobulin G
1
Etoposide
1
Docetaxel
1
Disulfides
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pharyngeal Neoplasms
×
Docetaxel
×
Head & Neck
×
Clear all
NCT00117572
2018-04-09
DeCIDE
University of Chicago
Phase 3
Completed
285 enrolled
22 charts